Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Arch Toxicol ; 88(1): 137-44, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23877121

ABSTRACT

Diethylstilbestrol is an estrogenic endocrine disrupter that has diverse health effects in humans. Bisphenol A is another estrogen-like chemical with possible similar effects to diethylstilbestrol, which has been increasingly used for industry to lead to globally widespread human exposure to it. Hematopoiesis is another of their possible targets, since estrogen suppresses erythropoietin induction to induce anemia. The aim of this study was to clarify the effects of diethylstilbestrol and bisphenol A on erythropoietin induction in rats. We observed the effects of one-shot subcutaneous injection of diethylstilbestrol or bisphenol A on hypoxia-, bleeding-, and cobalt-stimulated erythropoietin induction within 24 h and the hematological outcomes after repeated subcutaneous injection of diethylstilbestrol three times a week for 1 month in rats. Diethylstilbestrol at 10-1,000 µg/kg suppressed stimulus-elevated levels of plasma erythropoietin and its renal mRNA induction. In contrast, bisphenol A at 1,000 µg/kg did not suppress plasma erythropoietin elevated by any stimuli. Repeated injection of diethylstilbestrol at 1,000 µg/kg to rats for 1 month induced an anemic trend due to decelerated erythropoiesis through the insufficient production of erythropoietin, mimicking the effects of estradiol. In conclusion, diethylstilbestrol has a suppressive effect on erythropoietin induction, leading to deceleration of erythropoiesis and the development of anemia.


Subject(s)
Diethylstilbestrol/toxicity , Erythropoiesis/drug effects , Erythropoietin/metabolism , Anemia/chemically induced , Animals , Benzhydryl Compounds/toxicity , Diethylstilbestrol/administration & dosage , Endocrine Disruptors/toxicity , Female , Injections , Phenols/toxicity , Rats , Rats, Wistar
2.
J Rural Med ; 19(1): 1-9, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38196808

ABSTRACT

Objective: Non-alcoholic fatty liver disease is common worldwide, and lifestyle modifications are key to its treatment. This study aimed to identify the barriers to lifestyle modifications in patients with non-alcoholic fatty liver disease and to organize the results using the Capability Opportunity Motivation-Behavior (COM-B) model. Materials and Methods: The framework of Arksey and O' Malley was used in this scoping review. We searched PubMed, Scopus, and the Cochrane Library without language restrictions for reports published up to September 11, 2022, including peer-reviewed literature reporting barriers to lifestyle modifications in patients with non-alcoholic fatty liver disease. Patient-reported barriers were analyzed inductively and organized into the components (capability, opportunity, and motivation) of the COM-B model. Results: The literature search yielded 583 articles, of which seven qualitative studies, four quantitative studies, and one mixed-methods study met the inclusion criteria. Lack of time, lack of information on the diagnosis and management of non-alcoholic fatty liver disease, negative perceptions of the prescribed exercise and diet, physical symptoms interfering with the behavior, presence of comorbidities, and lack of family cooperation were frequently reported as barriers. Conclusion: The results of this study may contribute to the development of appropriate care and education strategies to promote behavioral changes in patients with non-alcoholic fatty liver disease.

3.
Tohoku J Exp Med ; 229(4): 287-99, 2013 04.
Article in English | MEDLINE | ID: mdl-23583960

ABSTRACT

Japan has a long history of fighting against great earthquakes that cause structural damage/collapses, fires and/or tsunami. On March 11, 2011 at 14:46 (Friday), the Great East-Japan Earthquake (magnitude 9.0) attacked the Tohoku region (northeastern Japan), which includes Sendai City. The earthquake generated a devastating tsunami, leading to unprecedented disasters (~18,500 victims) in coastal areas of Iwate, Miyagi and Fukushima prefectures, despite the fact that people living in the Tohoku region are well trained for tsunami-evacuation procedures, with the mindset of "Tsunami, ten-den-ko." This code means that each person should evacuate individually upon an earthquake. Sharing this rule, children and parents can escape separately from schools, houses or workplaces, without worrying about each other. The concept of ten-den-ko (individual evacuation) is helpful for people living in coastal areas of earthquake-prone zones around the world. It is also important to construct safe evacuation centers, because the March 11(th) tsunami killed people who had evacuated to evacuation sites. We summarize the current conditions of people living in the disaster-stricken areas, including the consequences of the Fukushima nuclear accident. We also describe the disaster responses as the publisher of the Tohoku Journal of Experimental Medicine (TJEM), located in Sendai, with online support from Tokyo. In 1923, the Great Kanto Earthquake (magnitude 7.9) evoked a massive fire that destroyed large areas of Tokyo (~105,000 victims), including the print company for TJEM, but the Wistar Institute printed three TJEM issues in 1923 in Philadelphia. Mutual aid relationships should be established between distant cities to survive future disasters.


Subject(s)
Disaster Planning/methods , Earthquakes/history , Fukushima Nuclear Accident , Relief Work , Tsunamis/history , Disaster Planning/trends , History, 20th Century , History, 21st Century , Japan , Periodicals as Topic
4.
Breast Cancer ; 30(5): 727-738, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37166625

ABSTRACT

BACKGROUND: Triple-negative breast cancer (TNBC) has an aggressive phenotype and poor outcome, however no specific targeted therapy has been established for TNBC lacking germline BRCA1/2 pathogenic variants. To develop a novel therapeutic strategy, we explored the potential of resveratrol (RSV) for TNBC treatment. METHODS: We investigated the effects of RSV on malignant phenotypes of TNBC cells as well as on apoptosis induced by ABT263, a specific inhibitor of BCL-2 and BCL-xL, using morphological observation, migration assay, ß-galactosidase staining, and Hoechst staining. To elucidate the underlying mechanisms of RSV-mediated effects, expression levels and histone acetylation levels of cadherin 1 (CDH1, E-cadherin) and cyclin dependent kinase inhibitor 1A (CDKN1A, p21) were determined by RT-qPCR, western blotting, and chromatin immunoprecipitation. Furthermore, knockdown analysis was conducted to evaluate the involvement of E-cadherin and/or p21 in RSV potentiation on cytotoxic activity of ABT263. RESULTS: RSV treatment induced epithelial-like cellular morphology and suppressed the migration capacity in MDA-MB-231 and BT-549-Luc TNBC cells. ß-galactosidase-positive cells were increased after RSV treatment, indicating the induction of cellular senescence, in MDA-MB-231 cells but not in BT-549-Luc cells. RSV increased the expression and histone acetylation of CDH1 and CDKN1A in both cells. Interestingly, pre-treatment with RSV enhanced the induction of apoptosis in the ABT263-treated MDA-MB-231 and BT-549-Luc cells, and knockdown of CDKN1A decreased ABT263-induced apoptosis in RSV-treated MDA-MB-231 cells. CONCLUSIONS: RSV represses the metastatic capacity and enhances the cytotoxic activity of ABT263 in TNBC cells. Our results suggested that RSV can potentially be used as a repressor of metastasis or a sensitizer to ABT263 for TNBC treatment via up-regulation of CDH1 and CDKN1A through epigenetic mechanisms.


Subject(s)
Antineoplastic Agents , Triple Negative Breast Neoplasms , Humans , Resveratrol/pharmacology , Resveratrol/therapeutic use , Triple Negative Breast Neoplasms/drug therapy , Triple Negative Breast Neoplasms/genetics , Triple Negative Breast Neoplasms/pathology , BRCA1 Protein/genetics , BRCA1 Protein/metabolism , Histones/genetics , Histones/metabolism , Histones/pharmacology , Cell Proliferation , Epigenesis, Genetic , Cell Line, Tumor , BRCA2 Protein/genetics , Antineoplastic Agents/therapeutic use , Apoptosis , Cadherins/genetics , Cadherins/metabolism
5.
Appl Microbiol Biotechnol ; 82(6): 1089-96, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19148632

ABSTRACT

Avermectin is an important macrocyclic polyketide produced by Streptomyces avermitilis and widely used as an anthelmintic agent in the medical, veterinary, and agricultural fields. The avermectin biosynthetic gene cluster contains aveR, which belongs to the LAL-family of regulatory genes. In this study, aveR was inactivated by gene replacement in the chromosome of S. avermitilis, resulting in the complete loss of avermectin production. The aveR mutant was unable to convert an avermectin intermediate to any avermectin derivatives, and complementation by intact aveR and its proper upstream region restored avermectin production in the mutant, suggesting that AveR is a positive regulator controlling the expression of both polyketide biosynthetic genes and postpolyketide modification genes in avermectin biosynthesis. Despite the general concept that an increased amount of a positive pathway-specific regulator leads to higher production, a higher amount of aveR resulted in complete loss of avermectin, indicating that there is a maximum threshold concentration of aveR for the production of avermectin.


Subject(s)
Bacterial Proteins/physiology , Gene Expression Regulation, Bacterial , Ivermectin/analogs & derivatives , Streptomyces/physiology , Transcription Factors/physiology , Bacterial Proteins/genetics , Gene Deletion , Genetic Complementation Test , Ivermectin/metabolism , Streptomyces/genetics , Transcription Factors/genetics
6.
J Vet Med Sci ; 78(6): 951-6, 2016 Jul 01.
Article in English | MEDLINE | ID: mdl-26902544

ABSTRACT

Currently, from the viewpoint of animal welfare, anesthesia or analgesia is required during experimental procedures in animals that are likely to cause pain. A part of these anesthetics have been reported to influence a blood biochemical level. It is important for us to understand the effect of the anesthetic on blood biochemistry when we choose the anesthetic agent to be used in experiments. In this study, we examined the blood biochemical changes in mice after administration of a new mixture of three anesthetic agents -medetomidine / midazolam / butorphanol (MMB). We subcutaneously administered two dose combinations of MMB (0.45 / 6 / 7.5 and 0.9 / 12 / 15 mg/kg) in mice, followed by administration of atipamezole, for reversal of anesthetic effects, after 1 hr. Thereafter, blood biochemistry was assessed at 1, 4 and 24 hr after MMB administration. We observed that MMB administration caused a transient increase in blood sugar, inorganic phosphorus, potassium and creatine kinase levels. These, however, returned to the reference range 24 hr after MMB administration. In conclusion, MMB changes the levels of some blood biochemical parameters, but not to an extent that would threaten health. However, when using laboratory animals, this effect of MMB may influence the experimental results, depending on the experimental content. Hence, the choice of anesthetic agents used in laboratory animals should be based on detailed knowledge of their pharmacological effects.


Subject(s)
Anesthetics, Combined/pharmacology , Butorphanol/pharmacology , Medetomidine/pharmacology , Midazolam/pharmacology , Anesthesia/veterinary , Anesthetics, Combined/administration & dosage , Animals , Blood Glucose/analysis , Butorphanol/administration & dosage , Creatine Kinase/blood , Male , Medetomidine/administration & dosage , Mice , Mice, Inbred C57BL , Midazolam/administration & dosage , Phosphorus/blood , Potassium/blood
7.
Springerplus ; 5(1): 885, 2016.
Article in English | MEDLINE | ID: mdl-27386333

ABSTRACT

This study aimed to evaluate the relationships between oxidative stress and heavy metal exposure (lead [Pb] and cadmium [Cd]), as well as co-factors such as physical activity and age, in Japanese women. This study was conducted with female subjects from a rural agricultural community in Japan. Subjects were asked to complete lifestyle-related questionnaires and undergo a group health examination. Physical activity, alcohol consumption, body mass index, and other demographic information were collected. Blood and urine samples were collected to measure urinary 8-hydroxydeoxyguanosine (8-OHdG) levels and blood and urinary Cd and Pb concentrations. Urine samples were analyzed using high performance liquid chromatography and flameless atomic absorption spectrometry; blood samples were analyzed using inductively coupled plasma-mass spectrometry. Age, physical activity, and blood and urinary Cd and Pb concentrations were included in structural equation modeling analysis. Two latent factors for heavy metal exposure and physical activity were produced to predict the total influence of the variables. The final model was good: CMIN/DF = 0.775, CFI = 1.000, GFI = 0.975, AGFI = 0.954, RMSEA = 0.000. 8-OHdG levels were positively associated with heavy metal exposure, physical activity, and age (standard ß of path analysis: 0.33, 0.38, and 0.20, respectively). Therefore, oxidative stress is associated with both, environmental and lifestyle factors, in combination with aging.

8.
Rev Environ Health ; 31(1): 33-5, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26953701

ABSTRACT

AIM: Exposure assessment of lead (Pb) and Arsenic (As) from food, water, and house dust intake were assessed among pregnant women, their children and fetuses in Pakistan and Japan, as well as their body burden of the metals in their blood. METHOD: Fifty families which included a pregnant woman, a fetus and the 1-3-year-old siblings were recruited in Karachi and Khairpur in Pakistan, and Shimotsuke and Asahikawa in Japan, respectively. Their dietary exposure to Pb and As was measured in 3-day food duplicates and drinking water by ICP-MP. Pb in house dust and respirable dust was evaluated with an energy dispersive X-ray fluorescence spectrometry. Non-radioactive isotope Pb profiles of blood specimens will be compared with those of the exposure origins, such as food duplicates, respirable house dust, the soils nearby, and gasoline. RESULTS: Judging from the data collected and analyzed so far, contribution from dietary intake is highly correlated to higher body burden of Pb among Pakistani mothers. Additional data analyses will reveal the status of Pb and As body burden in Pakistani mothers, fetuses and their siblings, and causal sources of high body burden is delineated by Pb isotope profile analysis of different sources of Pb exposure.


Subject(s)
Air Pollutants/analysis , Air Pollution, Indoor/analysis , Arsenic/analysis , Environmental Exposure , Food Contamination , Lead/analysis , Water Pollutants, Chemical/analysis , Adult , Air Pollutants/blood , Arsenic/blood , Body Burden , Child, Preschool , Cities , Dust/analysis , Female , Fetal Blood/chemistry , Fetus , Humans , Infant , Japan , Lead/blood , Male , Mothers , Pakistan , Pregnancy , Siblings , Water Pollutants, Chemical/blood , Young Adult
9.
Sci Rep ; 5: 15921, 2015 Nov 09.
Article in English | MEDLINE | ID: mdl-26549697

ABSTRACT

We recently reported that circulating apolipoprotein AII (apoAII) isoforms apoAII-ATQ/AT (C-terminal truncations of the apoAII homo-dimer) decline significantly in pancreatic cancer and thus might serve as plasma biomarkers for the early detection of this disease. We report here the development of novel enzyme-linked immunosorbent assays (ELISAs) for measurement of apoAII-ATQ/AT and their clinical applicability for early detection of pancreatic cancer. Plasma and serum concentrations of apoAII-ATQ/AT were measured in three independent cohorts, which comprised healthy control subjects and patients with pancreatic cancer and gastroenterologic diseases (n = 1156). These cohorts included 151 cases of stage I/II pancreatic cancer. ApoAII-ATQ/AT not only distinguished the early stages of pancreatic cancer from healthy controls but also identified patients at high risk for pancreatic malignancy. AUC values of apoAII-ATQ/AT to detect early stage pancreatic cancer were higher than those of CA19-9 in all independent cohorts. ApoAII-ATQ/AT is a potential biomarker for screening patients for the early stage of pancreatic cancer and identifying patients at risk for pancreatic malignancy (161 words).


Subject(s)
Apolipoprotein A-II/blood , Biomarkers, Tumor/blood , Early Detection of Cancer , Pancreatic Neoplasms/blood , Adult , Aged , Antibodies/immunology , Apolipoprotein A-II/immunology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Pancreatic Neoplasms/pathology , Risk Factors
10.
Mol Cell Endocrinol ; 192(1-2): 93-104, 2002 Jun 28.
Article in English | MEDLINE | ID: mdl-12088871

ABSTRACT

Tamoxifen is an estrogen receptor (ER)-antagonist that is widely used for the treatment of breast cancer, although it increases the risk of endometrial cancer. The mechanism mediating the stimulatory effect of tamoxifen on endometrial cancer is presently unknown. In this study we examined the effects of tamoxifen on Ishikawa 3H-12 endometrial cancer cells and MCF-7 breast cancer cells. Ishikawa cell growth was stimulated by 4-hydroxytamoxifen and accompanied by increased transcriptional activity of the endogenous ER. These stimulatory effects did not occur in MCF-7 cells. The relative transcriptional activity of the activation function (AF) 1 domain of ERalpha compared with that of the AF2 domain was 4-fold higher in Ishikawa cells than in MCF-7 cells. Mitogen-activated protein (MAP) kinase, which stimulates the transcriptional activity of AF1, was constitutively activated in Ishikawa cells, but not in MCF-7 cells. These observations suggest that the constitutively activated MAP kinase-signaling pathway in Ishikawa cells enhances the transcriptional activity of ERalpha via the AF1 domain. This ERalpha activation pathway may be involved in the stimulatory effect of tamoxifen on the development and/or progression of endometrial cancer.


Subject(s)
Carcinoma/pathology , Endometrial Neoplasms/pathology , Gene Expression Regulation, Neoplastic/drug effects , Neoplasms, Hormone-Dependent/pathology , Receptors, Estrogen/physiology , Selective Estrogen Receptor Modulators/pharmacology , Tamoxifen/analogs & derivatives , Tamoxifen/pharmacology , Adenocarcinoma/pathology , Breast Neoplasms/pathology , Carcinoma/chemically induced , Endometrial Neoplasms/chemically induced , Endometrium/metabolism , Estradiol/pharmacology , Estrogen Receptor alpha , Female , Humans , MAP Kinase Signaling System , Models, Biological , Nuclear Receptor Coactivator 3 , Protein Structure, Tertiary , Receptors, Estrogen/drug effects , Selective Estrogen Receptor Modulators/adverse effects , Signal Transduction/drug effects , Tamoxifen/adverse effects , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transcriptional Activation/drug effects , Tumor Stem Cell Assay
11.
J Steroid Biochem Mol Biol ; 86(3-5): 433-42, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14623541

ABSTRACT

Estrogen and its receptor play important roles in genesis and malignant progression of estrogen-dependent cancers, together with various growth factors. Functional cross-talk between estrogen-signaling and growth factor-mediated signaling pathways has been reported. Firstly, we show an example of the cross-talk that may alter the effect of antagonist on the breast and endometrial cancer cell growth. Our observations suggest that the constitutively activated MAP kinase-signaling pathway in endometrial cancer cells might enhance the transcriptional activity of ERalpha via phosphorylation of AF-1 domain. This mechanism may cause the growth stimulative effect of tamoxifen on the endometrium. Secondly, we show our recent study for comprehensive understanding of estrogen-signaling pathway using cDNA microarray. According to the results of the expression profiling of estrogen-responsive genes in ER-positive breast cancer cells using large-scale cDNA microarray, the custom-made cDNA microarray, on which only estrogen-responsive genes were loaded, was produced. Using this microarray consisting of the narrowed gene subset, we analyzed estrogen responsiveness of various cell lines and effect of estrogen antagonists. Aim of this study is not only to address the molecular mechanisms of estrogen-dependent growth of breast cancer, but also to develop the new diagnostic tools for responsiveness to hormone therapy of primary breast cancer patients. Finally, in order to understand the local tumor biology including stroma-cancer interaction, we recently developed the new analytical system using ERE-GFP introduced into breast cancer cells. Several observations indicated that these reporter cells were useful for assessment of stimulative effects of stroma cells adjacent to breast cancer on the estrogen-signaling pathway. These studies may provide not only new clues for elucidation of the molecular mechanisms of estrogen-dependent growth of breast cancer, but also assessment of anti-estrogen responses of individual breast cancer for patient-tailored hormone therapy.


Subject(s)
Breast Neoplasms/pathology , Endometrial Neoplasms/pathology , Estrogens/physiology , Growth Substances/physiology , Breast Neoplasms/drug therapy , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Cell Line, Tumor , Endometrial Neoplasms/metabolism , Estradiol/pharmacology , Estrogen Receptor alpha , Female , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Green Fluorescent Proteins , Humans , Luminescent Proteins/genetics , Mitogen-Activated Protein Kinases/metabolism , Oligonucleotide Array Sequence Analysis , Receptors, Estrogen/metabolism , Response Elements/genetics , Signal Transduction/drug effects , Stromal Cells/metabolism , Stromal Cells/pathology , Tamoxifen/pharmacology
12.
J Nutr Biochem ; 21(9): 856-64, 2010 Sep.
Article in English | MEDLINE | ID: mdl-19800779

ABSTRACT

Phytoestrogens have attracted attention as being safer alternatives to hormone replacement therapy (HRT) and as chemopreventive reagents for breast cancer because dietary soy isoflavone intake has been correlated with reduction in risk. To identify safe and effective phytoestrogen candidates for HRT and breast cancer prevention, we investigated the effects of daidzein, genistein, coumestrol, resveratrol and glycitein on cell growth, cell cycle, cyclin D1 expression, apoptosis, Bcl-2/Bax expression ratio and p53-dependent or NF-kappaB-dependent transcriptional activity in MCF-7 breast cancer cells. Phytoestrogens, except for glycitein, significantly enhanced estrogen-response-element-dependent transcriptional activity up to a level similar to that of 17beta-estradiol (E(2)). E(2) increased cell growth significantly, coumestrol increased cell growth moderately, and resveratrol and glycitein reduced cell growth. Phytoestrogens, except for glycitein, stimulated the promotion of cells to G(1)/S transition in cell cycle analysis, similar to E(2). This stimulation was accompanied by transient up-regulation of cyclin D1. While genistein, resveratrol and glycitein all increased apoptosis and reduced the Bcl-2/Bax ratio, resveratrol reduced this ratio more than either genistein or glycitein. Moreover, resveratrol significantly enhanced p53-dependent transcriptional activity, but slightly reduced NF-kappaB-dependent transcriptional activity. On knockdown analysis, genistein, resveratrol and glycitein all reduced the Bcl-2/Bax ratio in the presence of apoptosis-inducing stimuli, and estrogen receptor (ER) alpha silencing had no effect on these reductions. In contrast, in the absence of apoptosis-inducing stimuli, only resveratrol reduced the ratio, and ERalpha silencing abolished this reduction. Thus, resveratrol might be the most promising candidate for HRT and chemoprevention of breast cancer due to its estrogenic activity and high antitumor activity.


Subject(s)
Apoptosis/drug effects , Breast Neoplasms/pathology , Cell Proliferation/drug effects , Estrogen Receptor alpha/genetics , Phytoestrogens/pharmacology , Breast Neoplasms/genetics , Cell Cycle/drug effects , Cell Line, Tumor , Coumestrol/pharmacology , Estradiol/pharmacology , Female , Genistein/pharmacology , Humans , Isoflavones/pharmacology , Proto-Oncogene Proteins c-bcl-2/metabolism , Resveratrol , Stilbenes/pharmacology , bcl-2-Associated X Protein/metabolism
13.
Chem Pharm Bull (Tokyo) ; 50(1): 137-9, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11824576

ABSTRACT

A new biflavanone (1) with a C-3/C-3" linkage, a new daphnane-type diterpene (2) acylated by an unsaturated fatty acid, and a new coumarin glycoside (3), along with six lignans, two phenylpropanoids, five flavonoids, two diterpenes, and three coumarins were isolated from the roots of Stellera chamaejasme L. (Thymelaeaceae). Elucidation of these secondary metabolites of S. chamaejasme L. supplied strong chemical verification of the close taxonomic relationships among the genera Stellera, Daphne, and Wikstroemia, all of which belong to the family Thymelaeaceae.


Subject(s)
Coumarins/isolation & purification , Diterpenes/isolation & purification , Flavonoids/isolation & purification , Thymelaeaceae/chemistry , Chromatography, Gel , Coumarins/chemistry , Diterpenes/chemistry , Drugs, Chinese Herbal/chemistry , Flavonoids/chemistry , Magnetic Resonance Spectroscopy , Mass Spectrometry , Medicine, Chinese Traditional , Plant Roots/chemistry , Spectroscopy, Fourier Transform Infrared
SELECTION OF CITATIONS
SEARCH DETAIL